Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alphatec Holdings (ATEC) Non-cash Items (2017 - 2025)

Alphatec Holdings recorded quarterly Non-cash Items of $1.8 million in Q4 2025, down 86.19% quarter-over-quarter from $13.3 million in Q4 2024, and down 86.19% year-over-year from $13.3 million in Q4 2024.

Alphatec Holdings' Non-cash Items history runs 7 years deep, the most recent figure standing at $1.8 million for Q4 2025.

  • In Q4 2025, Non-cash Items fell 86.19% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (down 86.19% YoY), while the FY2025 annual figure was $1.8 million, down 86.19% from the prior year.
  • Non-cash Items came in at $1.8 million for Q4 2025 at Alphatec Holdings, down from $13.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $29.4 million in Q4 2023 to a low of $1.8 million in Q4 2025.
  • A 5-year average of $15.0 million and a median of $13.3 million in 2024 frame the typical range for Non-cash Items.
  • Across the five-year window, Non-cash Items tumbled 89.68% in 2022 and surged 933.56% in 2023, its largest moves.
  • Alphatec Holdings' Non-cash Items stood at $27.6 million in 2021, then sank by 89.68% to $2.8 million in 2022, then soared by 933.56% to $29.4 million in 2023, then sank by 54.84% to $13.3 million in 2024, then slumped by 86.19% to $1.8 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods registered $1.8 million, $13.3 million, and $29.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Alphatec Holdings 1.15 Bn 1.01 Bn 136.48 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.84 Mn
Dec 31, 2025 1.84 Mn
Dec 31, 2024 13.30 Mn
Dec 31, 2024 13.30 Mn
Dec 31, 2023 29.45 Mn
Dec 31, 2023 29.45 Mn
Dec 31, 2022 2.85 Mn
Dec 31, 2022 2.85 Mn
Dec 31, 2021 27.62 Mn
Dec 31, 2021 27.62 Mn
Dec 31, 2020 45.32 Mn
Dec 31, 2020 45.32 Mn
Dec 31, 2017 1.84 Mn
Dec 31, 2017 1.84 Mn
Sep 30, 2017 1.28 Mn
Sep 30, 2017 1.28 Mn